Taiwan FDA registration 1eac338d8a0bf627cc4aab2343eec17e

"Kabi" Aimeco blood component separator

TW: “卡比”愛美可血液成份分離機
Taiwan flagTaiwan·Risk Class 2·Fresenius Kabi AG;; PLEXUS MANUFACTURING SDN. BHD.·Registered Apr 05, 2018 – Apr 05, 2023Expired
Registration details
Analysis ID
1eac338d8a0bf627cc4aab2343eec17e
Customs Code
DHA05603053701
Company information
Manufacturer Country
Malaysia;;Germany
Authorized Representative
FRESENIUS KABI TAIWAN LIMITED
Product details
Intended Use
For details, it is Chinese approved copy of the imitation order.
Product Type (Level 1)
B Hematology, pathology, and genetics
Product Type (Level 2)
B.9245 Automated hemocytoseparator
Import Information
Input;; Contract manufacturing
Dates and status
Registration Date
Apr 05, 2018
Expiry Date
Apr 05, 2023
Companies making similar products

Top companies providing products similar to ""Kabi" Aimeco blood component separator"

Recent registrations

Recently registered similar products

About this record

Access comprehensive regulatory information for "Kabi" Aimeco blood component separator in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 1eac338d8a0bf627cc4aab2343eec17e and manufactured by Fresenius Kabi AG;; PLEXUS MANUFACTURING SDN. BHD.. The authorized representative in Taiwan is FRESENIUS KABI TAIWAN LIMITED.

This page provides complete technical specifications, regulatory compliance details, 1 companies making similar products including FRESENIUS KABI AG;; Fresenius HemoCare GmbH, and 1 recent registrations in the same category. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free DatabasePowered by Pure Global AI89,000+ Devices1 Competitors1 Recent Registrations